HRP20192218T1 - Humanizirani miševi koji izražavaju teške lance koji sadrže vl domene - Google Patents

Humanizirani miševi koji izražavaju teške lance koji sadrže vl domene Download PDF

Info

Publication number
HRP20192218T1
HRP20192218T1 HRP20192218TT HRP20192218T HRP20192218T1 HR P20192218 T1 HRP20192218 T1 HR P20192218T1 HR P20192218T T HRP20192218T T HR P20192218TT HR P20192218 T HRP20192218 T HR P20192218T HR P20192218 T1 HRP20192218 T1 HR P20192218T1
Authority
HR
Croatia
Prior art keywords
human
gene
segments
mouse
light chain
Prior art date
Application number
HRP20192218TT
Other languages
English (en)
Croatian (hr)
Inventor
Lynn Macdonald
Cagan Gurer
Karolina A. Meagher
Sean Stevens
Andrew J. Murphy
Original Assignee
Regeneron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceuticals, Inc. filed Critical Regeneron Pharmaceuticals, Inc.
Publication of HRP20192218T1 publication Critical patent/HRP20192218T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/462—Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/53—Hinge
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds
    • C07K2318/10—Immunoglobulin or domain(s) thereof as scaffolds for inserted non-Ig peptide sequences, e.g. for vaccination purposes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24046—Adamalysin (3.4.24.46)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Housing For Livestock And Birds (AREA)
  • Central Heating Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HRP20192218TT 2012-02-01 2013-02-01 Humanizirani miševi koji izražavaju teške lance koji sadrže vl domene HRP20192218T1 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261593463P 2012-02-01 2012-02-01
US201261677538P 2012-07-31 2012-07-31
EP13704329.5A EP2809150B1 (en) 2012-02-01 2013-02-01 Humanized mice that express heavy chains containing vl domains
PCT/US2013/024295 WO2013116609A1 (en) 2012-02-01 2013-02-01 Humanized rodents that express heavy chains containing vl domains

Publications (1)

Publication Number Publication Date
HRP20192218T1 true HRP20192218T1 (hr) 2020-03-06

Family

ID=47714588

Family Applications (2)

Application Number Title Priority Date Filing Date
HRP20192218TT HRP20192218T1 (hr) 2012-02-01 2013-02-01 Humanizirani miševi koji izražavaju teške lance koji sadrže vl domene
HRP20210987TT HRP20210987T1 (hr) 2012-02-01 2021-06-23 Humanizirani glodavci koji eksprimiraju teške lance koji sadrže vl domene

Family Applications After (1)

Application Number Title Priority Date Filing Date
HRP20210987TT HRP20210987T1 (hr) 2012-02-01 2021-06-23 Humanizirani glodavci koji eksprimiraju teške lance koji sadrže vl domene

Country Status (26)

Country Link
US (3) US20130212719A1 (cg-RX-API-DMAC7.html)
EP (3) EP3597038B1 (cg-RX-API-DMAC7.html)
JP (6) JP2015505477A (cg-RX-API-DMAC7.html)
KR (2) KR20190006029A (cg-RX-API-DMAC7.html)
CN (2) CN106117364B (cg-RX-API-DMAC7.html)
AU (3) AU2013204758B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014018843B1 (cg-RX-API-DMAC7.html)
CA (1) CA2863175A1 (cg-RX-API-DMAC7.html)
CY (2) CY1122419T1 (cg-RX-API-DMAC7.html)
DK (2) DK3597038T3 (cg-RX-API-DMAC7.html)
ES (2) ES2753774T3 (cg-RX-API-DMAC7.html)
HR (2) HRP20192218T1 (cg-RX-API-DMAC7.html)
HU (2) HUE046744T2 (cg-RX-API-DMAC7.html)
IL (3) IL233827A0 (cg-RX-API-DMAC7.html)
LT (2) LT3597038T (cg-RX-API-DMAC7.html)
ME (1) ME03611B (cg-RX-API-DMAC7.html)
MX (2) MX373286B (cg-RX-API-DMAC7.html)
NZ (5) NZ810648A (cg-RX-API-DMAC7.html)
PL (2) PL2809150T3 (cg-RX-API-DMAC7.html)
PT (2) PT2809150T (cg-RX-API-DMAC7.html)
RS (2) RS59699B1 (cg-RX-API-DMAC7.html)
RU (2) RU2664185C2 (cg-RX-API-DMAC7.html)
SG (3) SG10201606256TA (cg-RX-API-DMAC7.html)
SI (2) SI3597038T1 (cg-RX-API-DMAC7.html)
SM (2) SMT201900685T1 (cg-RX-API-DMAC7.html)
WO (1) WO2013116609A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2669298A3 (en) * 2008-05-23 2014-02-26 Ablexis, LLC Single variable immunoglobulin domain comprising VL-DH-JL
NO2792236T3 (cg-RX-API-DMAC7.html) 2009-07-08 2018-04-14
US9445581B2 (en) 2012-03-28 2016-09-20 Kymab Limited Animal models and therapeutic molecules
RS55495B1 (sr) 2010-08-02 2017-04-28 Regeneron Pharma Miševi koji stvaraju vezujuće proteine koji sadrže vl domene
IL273982B2 (en) 2011-08-05 2023-03-01 Regeneron Pharma Humanized mice possess a universal light chain
EP2758535B1 (en) 2011-09-19 2016-11-09 Kymab Limited Antibodies, variable domains&chains tailored for human use
EP2761008A1 (en) 2011-09-26 2014-08-06 Kymab Limited Chimaeric surrogate light chains (slc) comprising human vpreb
US9253965B2 (en) 2012-03-28 2016-02-09 Kymab Limited Animal models and therapeutic molecules
GB201122047D0 (en) * 2011-12-21 2012-02-01 Kymab Ltd Transgenic animals
BR112014015238B1 (pt) 2011-12-20 2022-11-16 Regeneron Pharmaceuticals, Inc Método ex vivo para preparar um anticorpo que se liga a um antígeno de interesse compreendendo identificar sequências de ácido nucleico a partir de linfócitos b de camundongo geneticamente modificado pela colocação de um gene adam6
HRP20192218T1 (hr) * 2012-02-01 2020-03-06 Regeneron Pharmaceuticals, Inc. Humanizirani miševi koji izražavaju teške lance koji sadrže vl domene
GB2502127A (en) 2012-05-17 2013-11-20 Kymab Ltd Multivalent antibodies and in vivo methods for their production
US10251377B2 (en) 2012-03-28 2019-04-09 Kymab Limited Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
MX364449B (es) 2012-06-12 2019-04-26 Regeneron Pharma Animales no humanos humanizados con loci de cadena pesada de inmunoglobulina restringidos.
EP2840892B1 (en) 2013-02-20 2018-04-18 Regeneron Pharmaceuticals, Inc. Non-human animals with modified immunoglobulin heavy chain sequences
US9788534B2 (en) 2013-03-18 2017-10-17 Kymab Limited Animal models and therapeutic molecules
US9783618B2 (en) 2013-05-01 2017-10-10 Kymab Limited Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
US11707056B2 (en) 2013-05-02 2023-07-25 Kymab Limited Animals, repertoires and methods
US9783593B2 (en) 2013-05-02 2017-10-10 Kymab Limited Antibodies, variable domains and chains tailored for human use
SG11201602236SA (en) 2013-10-01 2016-04-28 Kymab Ltd Animal models and therapeutic molecules
RU2016141123A (ru) 2014-03-21 2018-04-23 Регенерон Фармасьютикалз, Инк. Антигенсвязывающие белки vl, проявляющие различные связывающие характеристики
JP6636498B2 (ja) 2014-03-21 2020-01-29 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 単一ドメイン結合タンパク質を作る非ヒト動物
US11111314B2 (en) 2015-03-19 2021-09-07 Regeneron Pharmaceuticals, Inc. Non-human animals that select for light chain variable regions that bind antigen
EP4335918A3 (en) * 2015-04-03 2024-04-17 Dana-Farber Cancer Institute, Inc. Composition and methods of genome editing of b-cells
EP3440194A1 (en) * 2016-04-04 2019-02-13 ETH Zurich Mammalian cell line for protein production and library generation
NZ747857A (en) 2016-05-20 2023-01-27 Regeneron Pharma Methods for breaking immunological tolerance using multiple guide rnas
WO2018183946A1 (en) * 2017-03-30 2018-10-04 Utah State University Transgenic silkworms expressing spider silk
WO2019113065A1 (en) * 2017-12-05 2019-06-13 Regeneron Pharmaceuticals, Inc. Non-human animals having an engineered immunoglobulin lambda light chain and uses thereof
EP3772927B1 (en) * 2018-03-24 2025-01-15 Regeneron Pharmaceuticals, Inc. Genetically modified mice or rats for generating therapeutic antibodies against peptide-mhc complexes, methods of making and uses thereof
IL318469A (en) * 2018-06-14 2025-03-01 Regeneron Pharma Non-human animals capable of reorganizing transgenic DH-DH, and their uses
TW202229328A (zh) 2020-09-11 2022-08-01 美商再生元醫藥公司 抗原特異性抗體之鑑定及產生
JP2024500399A (ja) 2020-12-16 2024-01-09 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒト化Ｆｃアルファ受容体を発現するマウス
CN114645042A (zh) * 2020-12-18 2022-06-21 中国食品药品检定研究院 一种构建具有表达荧光素酶和红色荧光蛋白的重组巨噬细胞的转基因小鼠的方法
CN114196626A (zh) * 2022-02-16 2022-03-18 北京国卫生物科技有限公司 脐带间充质干细胞及其分离培养扩增方法
AU2024329875A1 (en) * 2024-01-02 2025-07-17 Gempharmatech Co., Ltd Animal model generating humanized antibody and construction method thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774279B2 (en) 1997-05-30 2004-08-10 Carnegie Institution Of Washington Use of FLP recombinase in mice
US7129084B2 (en) * 2000-08-03 2006-10-31 Therapeutic Human Polyclonals, Inc. Production of humanized antibodies in transgenic animals
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
CN101016543A (zh) * 2000-11-17 2007-08-15 罗切斯特大学 筛选编码抗原特异性免疫球蛋白分子或其抗原特异性片段的多核苷酸的方法
US7473557B2 (en) 2001-06-06 2009-01-06 Regeneron Pharmaceuticals, Inc. Method for targeting transcriptionally active loci
CN100526455C (zh) 2001-12-21 2009-08-12 斯路姆-X股份有限公司 用于体外分离和培养具有种系传递能力的胚胎干细胞(es)细胞系的组合物
AU2003230741A1 (en) * 2002-03-22 2003-10-13 Origen Therapeutics Transgenic aves producing human polyclonal antibodies
CN103205436B (zh) * 2003-07-15 2016-05-25 人类多克隆治疗公司 人源化免疫球蛋白基因座
EP1802193B1 (en) 2004-10-19 2014-04-30 Regeneron Pharmaceuticals, Inc. Method for generating a mouse homozygous for a genetic modification
WO2006047367A2 (en) * 2004-10-22 2006-05-04 Therapeutic Human Polyclonals, Inc. Suppression of endogenous immunoglubolin expression in non-human transgenic animals
AU2007235496B2 (en) * 2006-03-31 2013-11-21 E. R. Squibb & Sons, L.L.C. Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
SG174053A1 (en) * 2006-09-01 2011-09-29 Therapeutic Human Polyclonals Inc Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
AU2008294074B2 (en) * 2007-08-30 2015-01-22 Walter And Eliza Hall Institute Of Medical Research Dendritic cell marker and uses thereof
WO2009041613A1 (ja) * 2007-09-26 2009-04-02 Chugai Seiyaku Kabushiki Kaisha 抗体定常領域改変体
US7659842B2 (en) 2007-10-24 2010-02-09 Infineon Technologies Ag Quantization error reduction in PWM full-MASH converters
EP2669298A3 (en) * 2008-05-23 2014-02-26 Ablexis, LLC Single variable immunoglobulin domain comprising VL-DH-JL
CN102123582B (zh) * 2008-06-27 2015-09-30 莫鲁斯有限公司 产生抗体的非人哺乳动物
WO2010022738A1 (en) * 2008-08-29 2010-03-04 Symphogen A/S Method for cloning avian-derived antibodies
CA2983133A1 (en) * 2009-02-04 2010-08-12 Molecular Innovations Methods for screening candidate agents for modulating prorenin and renin, assays for detecting prorenin, and antibodies used therein
NO2792236T3 (cg-RX-API-DMAC7.html) * 2009-07-08 2018-04-14
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
CN105695415A (zh) * 2010-06-17 2016-06-22 科马布有限公司 动物模型及治疗分子
RS55495B1 (sr) * 2010-08-02 2017-04-28 Regeneron Pharma Miševi koji stvaraju vezujuće proteine koji sadrže vl domene
ES2946169T3 (es) * 2011-02-25 2023-07-13 Regeneron Pharma Ratones ADAM6
IL273982B2 (en) * 2011-08-05 2023-03-01 Regeneron Pharma Humanized mice possess a universal light chain
BR112014015238B1 (pt) * 2011-12-20 2022-11-16 Regeneron Pharmaceuticals, Inc Método ex vivo para preparar um anticorpo que se liga a um antígeno de interesse compreendendo identificar sequências de ácido nucleico a partir de linfócitos b de camundongo geneticamente modificado pela colocação de um gene adam6
HRP20192218T1 (hr) * 2012-02-01 2020-03-06 Regeneron Pharmaceuticals, Inc. Humanizirani miševi koji izražavaju teške lance koji sadrže vl domene
MX364449B (es) * 2012-06-12 2019-04-26 Regeneron Pharma Animales no humanos humanizados con loci de cadena pesada de inmunoglobulina restringidos.
DK4082334T3 (da) * 2016-11-04 2025-06-02 Regeneron Pharma Ikke humane dyr med et modificeret immunglobulin-lambda-letkædelocus

Also Published As

Publication number Publication date
NZ627977A (en) 2016-06-24
CN104202971A (zh) 2014-12-10
PL2809150T3 (pl) 2020-04-30
CN104202971B (zh) 2016-07-06
US20210368751A1 (en) 2021-12-02
AU2017251848B2 (en) 2020-02-20
RU2018122695A3 (cg-RX-API-DMAC7.html) 2021-10-06
JP6698718B2 (ja) 2020-05-27
IL233827A0 (en) 2014-09-30
JP2021137030A (ja) 2021-09-16
HUE046744T2 (hu) 2020-03-30
BR112014018843A2 (pt) 2017-07-04
EP3912465A1 (en) 2021-11-24
MX2020003491A (es) 2022-10-25
IL261280B (en) 2019-08-29
DK2809150T3 (da) 2019-12-09
PT3597038T (pt) 2021-05-10
JP2015505477A (ja) 2015-02-23
PL3597038T3 (pl) 2021-11-08
AU2013204758A1 (en) 2013-08-15
SI2809150T1 (sl) 2019-11-29
RU2018122695A (ru) 2019-03-06
SMT201900685T1 (it) 2020-01-14
RU2770016C2 (ru) 2022-04-14
AU2015246154A1 (en) 2015-11-12
AU2015246154B2 (en) 2017-11-23
CN106117364A (zh) 2016-11-16
HUE055610T2 (hu) 2021-12-28
US20130212719A1 (en) 2013-08-15
BR112014018843A8 (pt) 2019-01-29
ES2753774T3 (es) 2020-04-14
EP2809150A1 (en) 2014-12-10
IL268675A (en) 2019-10-31
HK1202771A1 (en) 2015-10-09
RU2014133653A (ru) 2016-03-20
EP3597038A1 (en) 2020-01-22
ES2870703T3 (es) 2021-10-27
KR20190006029A (ko) 2019-01-16
BR112014018843B1 (pt) 2024-02-20
LT2809150T (lt) 2019-10-25
HRP20210987T1 (hr) 2021-09-17
JP6942757B2 (ja) 2021-09-29
NZ734504A (en) 2022-10-28
JP2023168590A (ja) 2023-11-24
RS62023B1 (sr) 2021-07-30
SMT202100401T1 (it) 2021-09-14
IL268675B (en) 2020-11-30
AU2013204758B2 (en) 2015-07-23
DK3597038T3 (da) 2021-06-28
MX2019002517A (es) 2019-06-17
SG11201404477YA (en) 2014-08-28
SI3597038T1 (sl) 2021-07-30
RU2664185C2 (ru) 2018-08-15
JP2023014242A (ja) 2023-01-26
CN106117364B (zh) 2021-08-31
US20170094955A1 (en) 2017-04-06
IL261280A (en) 2018-10-31
KR20140123983A (ko) 2014-10-23
CY1122419T1 (el) 2021-01-27
EP3597038B1 (en) 2021-04-21
CA2863175A1 (en) 2013-08-08
JP2019170395A (ja) 2019-10-10
SG10201913428QA (en) 2020-03-30
SG10201606256TA (en) 2016-09-29
JP2018075041A (ja) 2018-05-17
JP7525579B2 (ja) 2024-07-30
LT3597038T (lt) 2021-05-25
NZ719228A (en) 2022-08-26
NZ793447A (en) 2024-05-31
WO2013116609A1 (en) 2013-08-08
RS59699B1 (sr) 2020-01-31
JP7187615B2 (ja) 2022-12-12
AU2017251848A1 (en) 2017-11-16
NZ810648A (en) 2025-11-28
EP2809150B1 (en) 2019-09-18
ME03611B (me) 2020-07-20
CY1124361T1 (el) 2022-07-22
MX373286B (es) 2020-05-20
PT2809150T (pt) 2019-12-09

Similar Documents

Publication Publication Date Title
HRP20192218T1 (hr) Humanizirani miševi koji izražavaju teške lance koji sadrže vl domene
HRP20210916T1 (hr) Miševi s ljudskim univerzalnim lakim lancem
JP2021137030A5 (cg-RX-API-DMAC7.html)
JP2015505477A5 (cg-RX-API-DMAC7.html)
HRP20190897T1 (hr) Laki lanac humaniziranih miševa
HRP20171357T1 (hr) Ograničeni teški lanac imunoglobulina u miševa
HRP20201634T1 (hr) Monoklonsko protutijelo protiv interleukina-31
JP2015502177A5 (cg-RX-API-DMAC7.html)
RU2013102595A (ru) Мыши, экспрессирующие гибридную легкую цепь иммуноглобулина
WO2012145469A8 (en) Human monoclonal antibodies specific for glypican-3 and use thereof
HRP20170322T1 (hr) Miševi koji stvaraju vl vezne proteine
JP2014110814A5 (cg-RX-API-DMAC7.html)
HRP20191680T1 (hr) Neljudske životinje koje izražavaju antitijela sa zajedničkim lakim lancem
NZ711451A (en) Anti-c5 antibodies having improved pharmacokinetics
HRP20191333T1 (hr) Glodavci koji izražavaju sekvence imunoglobulina osjetljive na ph vrijednost
HRP20230490T1 (hr) Miševi koji izražavaju ograničeni repertoar lakog lanca imunoglobulina
JP2014524243A5 (cg-RX-API-DMAC7.html)
HRP20220888T1 (hr) Ne-humane životinje koje imaju konstruirani lokus imunoglobulinskog lamba lakog lanca
ME02678B (me) Antitijela na ox-40 i postupci njihove primjene
HK1250038A1 (zh) 选择结合抗原的轻链可变区的非人动物
BR112016021572A2 (pt) Métodos para preparar um animal não humano geneticamente modificado e para produzir proteínas de ligação, hibridoma, ácido nucleico, célula, e, proteína de ligação
HRP20220081T1 (hr) Bcma i cd3 bispecifična t stanica koja uključuje konstrukte protutijela
ME02817B (me) Generisanje vezujućih molekula
MX2015012540A (es) Ratón de cadena ligera común.
RU2019121863A (ru) Антитела со встроенным в легкие цепи гистидином и генетически модифицированные отличные от человека животные для их получения